N@N

AtriCure Announces September Investor Conference Schedule

^{Published on 2010-09-08 12:16:10 - Market Wire}
 

WEST CHESTER, Ohio--([ BUSINESS WIRE ])--AtriCure, Inc. (Nasdaq: ATRC), a medical device company and a leader in cardiac surgical ablation systems and systems for the exclusion of the left atrial appendage, today announced that it will participate in the following investor conferences during September:

• The UBS Global Life Sciences Conference at the Grand Hyatt New York. Management is scheduled to present at 3:00 p.m. Eastern Time on Tuesday, September 21, 2010.
• The JMP Securities Healthcare Conference at the New York Palace Hotel. Management is scheduled to present at 10:00 a.m. Eastern Time on Tuesday, September 28, 2010.

A live audio webcast and replay of the presentations will be available for 30 days following the presentation at [ www.atricure.com ].

About AtriCure, Inc.

AtriCure, Inc. is a medical device company and a leader in developing, manufacturing and selling innovative cardiac surgical ablation systems designed to create precise lesions, or scars, in cardiac, or heart, tissue and systems for the exclusion of the left atrial appendage. For more information, please visit [ www.atricure.com ].